VDAC1 and cardiovascular disorder: Inhibiting apoptosis at an early stage via prevention of VDAC1 oligomerization may be an effective approach for blocking or slowing apoptosis in neurodegenerative disorders 135, 136 and various cardiovascular diseases, where enhanced apoptosis also occurs 137, 138, 139.